INSTITUT CLAUDIUS REGAUD
A Trial Evaluating Stereotactic Radiotherapy Plus Durvalumab Continuation for Patients With NSCLC Metachronous Oligometastatic Disease Under Durvalumab Consolidation Following Chemoradiation
- Conditions
- NSCLC
- First Posted Date
- 2019-05-20
- Last Posted Date
- 2024-02-29
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 4
- Registration Number
- NCT03955198
- Locations
- 🇫🇷
Institut de Cancérologie de Bourgogne - Auxerre, Auxerre, France
🇫🇷Institut Sainte-Catherine, Avignon, France
🇫🇷Centre François Baclesse, Caen, France
Evaluation of PET-CT Scanner Performances to Detect Infra-centimetric Lesions in Patients With Cancer
- Conditions
- Cancer
- First Posted Date
- 2019-05-20
- Last Posted Date
- 2021-02-10
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 24
- Registration Number
- NCT03956459
- Locations
- 🇫🇷
Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France
Platino-resistance in Ovarian Cancer
- Conditions
- Epithelial Ovarian Cancer
- First Posted Date
- 2019-05-17
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 600
- Registration Number
- NCT03954171
- Locations
- 🇫🇷
Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France
Evaluation of the Automatic Deformable Recontouring on the Daily MVCT for Head and Neck Cancer Adaptive Radiotherapy
- Conditions
- Head and Neck Cancer
- First Posted Date
- 2019-05-16
- Last Posted Date
- 2020-09-01
- Lead Sponsor
- Institut Claudius Regaud
- Registration Number
- NCT03953352
- Locations
- 🇫🇷
Institut Universitaire Du Cancer Toulouse - Oncopole (Iuct-O), Toulouse, France
Chronic Pain and Minor Breast Cancer Surgery
- Conditions
- Pain, PostoperativeSurgeryPain, ChronicBreast Cancer
- First Posted Date
- 2019-04-11
- Last Posted Date
- 2020-03-04
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 205
- Registration Number
- NCT03912948
- Locations
- 🇫🇷
Institut Claudius Regaud - IUCT-Oncopole, Toulouse, Occitanie, France
Evaluation of Pain and Postoperative Nausea Vomiting Incidence in Outpatient Surgery at IUCT-Oncopole Hospital
- Conditions
- CancerAnesthesiaSurgery
- First Posted Date
- 2018-09-13
- Last Posted Date
- 2018-09-13
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 200
- Registration Number
- NCT03669328
- Locations
- 🇫🇷
Institut Claudius Regaud, Toulouse, Occitanie, France
FALCOn (Facteur AnthropoLogique Cancer Orl)
- Conditions
- Head and Neck CancerHead and Neck Carcinoma
- First Posted Date
- 2018-09-10
- Last Posted Date
- 2020-03-03
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 206
- Registration Number
- NCT03663985
- Locations
- 🇫🇷
Institut Claudius Regaud, Toulouse, Occitanie, France
Prospective, Multicentric Study Evaluating the Surgical Treatment by Mastectomy With Immediate Prosthetic Breast Reconstruction in Patients With Breast Cancer and Receiving Adjuvant Therapy by TomoTherapy +/-Chemotherapy.
- Conditions
- Breast Cancer Invasive
- First Posted Date
- 2018-08-14
- Last Posted Date
- 2024-06-18
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 65
- Registration Number
- NCT03627988
- Locations
- 🇫🇷
Institut Bergonie, Bordeaux, France
🇫🇷Institut Universitaire Du Cancer de Toulouse - Oncopole, Toulouse, France
Evaluation of Sphingolipids as Predictive Biomarkers of Immune Checkpoint Inhibitor Response in Melanoma Patients
- Conditions
- Melanoma
- First Posted Date
- 2018-08-13
- Last Posted Date
- 2024-06-10
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 78
- Registration Number
- NCT03627026
- Locations
- 🇫🇷
Chu Nantes, Nantes, France
🇫🇷Institut Universitaire Du Cancer de Toulouse - Oncopole, Toulouse, France
Cisplatin or ImmunoTHerapy in Association With Definitive Radiotherapy in HPV-related oropharyngEal Squamous Cell Carcinoma: a Randomized Phase II Trial.
- Conditions
- Oropharyngeal Squamous Cell Carcinoma
- Interventions
- Drug: Immunotherapy + Radiotherapy armDrug: Chemoradiotherapy arm
- First Posted Date
- 2018-08-09
- Last Posted Date
- 2023-02-17
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 11
- Registration Number
- NCT03623646
- Locations
- 🇫🇷
CHU Bordeaux, Bordeaux, France
🇫🇷Centre Jean Perrin, Clermont-Ferrand, France
🇫🇷Institut Universitaire du Cancer Toulouse (IUCT-O), Toulouse, France